See also this year's filing and all EDGAR filings for this company.
PDF Report 0001439222_2023_AGIOS_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001439222, AGIOS PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 832,772,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 22,987,000 |
| 3 | remainder_Assets | 382,959,000 |
| 4 | LiabilitiesCurrent | 62,629,000 |
| 5 | LiabilitiesNoncurrent | 75,275,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,704,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 121,673,000 |
| 9 | ResearchAndDevelopmentExpense | 279,910,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 14,240,000 |
| 12 | remainder_NetIncome | 157,246,000 |
| 13 | remainder_ComprehensiveNetIncome | -11,337,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,238,718,000 |
| 1 | Liabilities | 137,904,000 |
| 2 | Expenses | 403,287,000 |
| 3 | Revenues | 14,240,000 |
| 4 | StockholdersEquity | 1,100,814,000 |
| 5 | NetIncome | -231,801,000 |
| 6 | ComprehensiveNetIncome | -237,469,500 |
| 7 | BaseVar | 981,366,000 |
| 8 | EconomicCapitalRatio | 2.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
